Not recruiting
Investigational
Study on Nipocalimab for Adults with Active Inflammatory Muscle Diseases
Investigational
- Substances:Nipocalimab
Countries:
Poland
Poland- Participants:18–64 years · 65+ years
- Substances:Nipocalimab
Find therapies in clinical trials near you – page 47
- recruiting
- 3 968
- countries
- 28
- conditions
- 2 103
3 968 trials recruiting28 European countries2 103 conditions coveredUpdated today
723 trials match your criteria
Not recruiting
Bladder cancer
Not recruitingRegistered drugNo placebo
Study of Pembrolizumab and Enfortumab Vedotin with Surgery vs. Surgery Alone for Patients with Muscle-Invasive Bladder Cancer Who Cannot or Choose Not to Use Cisplatin
Registered drugNo placebo
- Disease:Bladder cancer
- Substances:Pembrolizumab
Countries:Poland
Poland- Participants:18–64 years · 65+ years
- Substances:Pembrolizumab
Not recruiting
Non-small cell lung cancer metastatic
Not recruitingRegistered drugNo placebo
Study Comparing MK-2870 with Chemotherapy (Docetaxel or Pemetrexed) for Patients with Advanced Non-Small Cell Lung Cancer with EGFR Mutations
Registered drugNo placebo
- Disease:Non-small cell lung cancer metastatic
- Substances:Acetylsalicylic AcidAnhydrous Docetaxel+4
Countries:Poland
Poland- Participants:18–64 years · 65+ years
- Substances:Acetylsalicylic Acid
Not recruiting
Dementia Alzheimer's type
Not recruitingRegistered drug
Study on Bepranemab for Patients with Early Alzheimer's Disease
Registered drug
- Disease:Dementia Alzheimer's type
- Substances:BepranemabFlorbetaben (18F)+1
Countries:Poland
Poland- Participants:18–64 years · 65+ years
- Substances:Bepranemab
Not recruiting
B-cell lymphoma refractory
Not recruitingRegistered drugNo placebo
Study of Epcoritamab for Patients with Relapsed, Progressive, or Refractory B-Cell Lymphoma
Registered drugNo placebo
- Disease:B-cell lymphoma refractory
- Substances:AnakinraCodeine Phosphate+7
Countries:Poland
Poland- Participants:18–64 years · 65+ years
- Substances:Anakinra
Not recruiting
Non-small cell lung cancer
Not recruitingRegistered drugNo placebo
Study of Amivantamab, Lazertinib, and Drug Combination for Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer After Osimertinib Failure
Registered drugNo placebo
- Disease:Non-small cell lung cancer
- Substances:AmivantamabCarboplatin+3
Countries:Poland
Poland- Participants:18–64 years · 65+ years
- Substances:Amivantamab
Not recruiting
Multiple sclerosis+1
Not recruitingRegistered drug
Study on the Effects of a Higher Dose of Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis
Registered drug
- Disease:Multiple sclerosisPrimary progressive multiple sclerosis
- Substances:MethylprednisoloneOcrelizumab+2
Countries:Poland
Poland- Participants:18–64 years
- Substances:Methylprednisolone
Not recruiting
Multiple sclerosis+2
Not recruitingRegistered drug
Study on the Effects of a Higher Dose of Ocrelizumab for Adults with Relapsing Multiple Sclerosis
Registered drug
- Disease:Multiple sclerosisRelapsing-remitting multiple sclerosis+1
- Substances:MethylprednisoloneOcrelizumab+2
Countries:Poland
Poland- Participants:18–64 years
- Substances:Methylprednisolone
Not recruiting
Non-small cell lung cancer
Not recruitingRegistered drug
Study on Durvalumab with Oleclumab or Monalizumab for Patients with Stage III Unresectable Non-Small Cell Lung Cancer After Chemoradiation Therapy
Registered drug
- Disease:Non-small cell lung cancer
- Substances:DurvalumabGlucose+5
Countries:Poland
Poland- Participants:18–64 years · 65+ years
- Substances:Durvalumab
Not recruiting
Type 2 diabetes mellitus
Not recruitingRegistered drugNo placebo
Study Comparing Orforglipron and Dapagliflozin for Adults with Type 2 Diabetes and Poor Blood Sugar Control on Metformin
Registered drugNo placebo
- Disease:Type 2 diabetes mellitus
- Substances:DapagliflozinMetformin
Countries:Poland
Poland- Participants:18–64 years · 65+ years
- Substances:Dapagliflozin
Not recruiting
Chronic rhinosinusitis with nasal polyps
Not recruitingRegistered drug
Study on Benralizumab and Mometasone Furoate for Patients with Severe Eosinophilic Chronic Rhinosinusitis with Nasal Polyps and Asthma
Registered drug
- Disease:Chronic rhinosinusitis with nasal polyps
- Substances:BenralizumabMometasone Furoate
Countries:Poland
Poland- Participants:18–64 years · 65+ years
- Substances:Benralizumab
Not recruiting
Breast cancer+3
Not recruitingRegistered drug
Study of Capivasertib and Fulvestrant for Patients with Advanced or Metastatic HR+/HER2- Breast Cancer
Registered drug
- Disease:Breast cancerBreast cancer metastatic+2
- Substances:CapivasertibFulvestrant
Countries:Poland
Poland- Participants:18–64 years · 65+ years
- Substances:Capivasertib